Sean E. Aeder

Array ( [id] => 6070127 [patent_doc_number] => 20110044977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Subcutaneous anti-HER2 antibody formulations and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/804703 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24808 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044977.pdf [firstpage_image] =>[orig_patent_app_number] => 12804703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8172182 [patent_doc_number] => 20120107826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'ZNF217 A New Prognostic And Predictive Biomarker Of Recurrent Invasive And Metastatic Phenotypes In Breast Cancer' [patent_app_type] => utility [patent_app_number] => 13/383693 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17222 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107826.pdf [firstpage_image] =>[orig_patent_app_number] => 13383693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136263 [patent_doc_number] => 20110009342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'USES OF PDCD5 POLYPEPTIDE FOR TUMOR CHEMOTHERAPY AND ORGAN PROTECTION' [patent_app_type] => utility [patent_app_number] => 12/838039 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14479 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009342.pdf [firstpage_image] =>[orig_patent_app_number] => 12838039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007823 [patent_doc_number] => 20110059854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'DIAGNOSTIC AND PROGNOSTIC TESTS' [patent_app_type] => utility [patent_app_number] => 12/834316 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37975 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059854.pdf [firstpage_image] =>[orig_patent_app_number] => 12834316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588791 [patent_doc_number] => 20100291581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Aldehyde Dehydrogenase 1 (ALDH1) as a Cancer Stem Cell Marker' [patent_app_type] => utility [patent_app_number] => 12/830993 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18429 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291581.pdf [firstpage_image] =>[orig_patent_app_number] => 12830993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8351852 [patent_doc_number] => 08247182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Upregulation of rack-1 in melanoma and its use as a marker' [patent_app_type] => utility [patent_app_number] => 12/830775 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11556 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12830775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469598 [patent_doc_number] => 08298776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Antibodies to tumor associated proteins' [patent_app_type] => utility [patent_app_number] => 12/829256 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 72 [patent_no_of_words] => 162992 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12829256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266475 [patent_doc_number] => 20100298233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COMPOSITIONS AND METHODS RELATED TO PROFILING A PLURALITY OF CELLS BASED ON PEPTIDE BINDING' [patent_app_type] => utility [patent_app_number] => 12/826327 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26862 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298233.pdf [firstpage_image] =>[orig_patent_app_number] => 12826327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146686 [patent_doc_number] => 08163691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways' [patent_app_type] => utility [patent_app_number] => 12/825668 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 35 [patent_no_of_words] => 22955 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163691.pdf [firstpage_image] =>[orig_patent_app_number] => 12825668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8188767 [patent_doc_number] => 08182983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Method for determining immune system affecting compounds' [patent_app_type] => utility [patent_app_number] => 12/822013 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 26 [patent_no_of_words] => 27656 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182983.pdf [firstpage_image] =>[orig_patent_app_number] => 12822013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4431155 [patent_doc_number] => 07968090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 12/820279 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 97 [patent_no_of_words] => 174041 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968090.pdf [firstpage_image] =>[orig_patent_app_number] => 12820279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234708 [patent_doc_number] => 20100266498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 125P5C8 USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/820083 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 114718 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266498.pdf [firstpage_image] =>[orig_patent_app_number] => 12820083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8208982 [patent_doc_number] => 20120128651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/375184 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13276 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128651.pdf [firstpage_image] =>[orig_patent_app_number] => 13375184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488766 [patent_doc_number] => 08029787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Method of diagnosing, monitoring, staging, imaging and treating various cancers' [patent_app_type] => utility [patent_app_number] => 12/787675 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9077 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/029/08029787.pdf [firstpage_image] =>[orig_patent_app_number] => 12787675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234976 [patent_doc_number] => 20100266680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Treatment of Cancer Using TLR3 Agonists' [patent_app_type] => utility [patent_app_number] => 12/787832 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27505 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266680.pdf [firstpage_image] =>[orig_patent_app_number] => 12787832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807992 [patent_doc_number] => 08445644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'ErbB interface peptidomimetics and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/787594 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 28450 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12787594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392220 [patent_doc_number] => 20100303836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'TREATMENT OF HYPERPROLIFERATIVE DISEASE WITH SUPERANTIGENS IN COMBINATION WITH ANOTHER ANTICANCER AGENT' [patent_app_type] => utility [patent_app_number] => 12/787095 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 46893 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303836.pdf [firstpage_image] =>[orig_patent_app_number] => 12787095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6265006 [patent_doc_number] => 20100297676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/784478 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 47372 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297676.pdf [firstpage_image] =>[orig_patent_app_number] => 12784478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266576 [patent_doc_number] => 20100298255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Methods for providing personalized medicine test ex vivo for hematological neoplasms' [patent_app_type] => utility [patent_app_number] => 12/783465 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 41927 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298255.pdf [firstpage_image] =>[orig_patent_app_number] => 12783465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555164 [patent_doc_number] => 08329636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Carcinoma diagnosis and treatment, based on ODC1 genotype' [patent_app_type] => utility [patent_app_number] => 12/780592 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24008 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12780592 [rel_patent_id] =>[rel_patent_doc_number] =>)